Skip to main content
OpenTrials
Completed

NCT Number: NCT05076747

Exercise and Genotype in Sub-acute Stroke

This study will investigate the impact of cardiovascular exercise on brain plasticity among patients in sub-acute stages after stroke, and whether genotype modulates the response to this intervention. Participants in the experimental group will perform cardiovascular training for 8 weeks, three times/week in addition to standard therapy, while participants in the control group will perform standard therapy only. Assessments will be performed at baseline, four weeks, and 8 weeks after training.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jewish Rehabiliation Hospital

Laval, Quebec, H7V 1R2, Canada

About this study

Background: Research has shown that the adult human brain has an enormous plastic capacity to adapt after injury. In people who have recently experienced a stroke, interventions that promote brain plasticity in early stages after stroke can improve long-term recovery. Cardiovascular exercise is a simple strategy to increase brain plasticity and promote neural reorganization. However, there is no information about the effects of cardiovascular exercise on brain plasticity in early phases of stroke, despite the importance of this initial period for long-term recovery. Similarly, it is not known if, depending on their genetic profile, some people will be more responsive than others to this type of exercise.

Objectives: To establish whether: 1) cardiovascular exercise improves brain plasticity during the initial phases of post-stroke recovery; 2) carrying a specific form of the BDNF gene modulates the response to cardiovascular exercise.

Design: 70 participants will perform either a progressive high-intensity cardiovascular exercise program or low-intensity stretching and toning exercise program. Both groups will undergo 8 weeks of training performed 3 times per week. Assessments will be performed at the beginning, mid-point (4 weeks) and at the end of the training period (8 weeks).

Methodology: Assessments: 1) brain plasticity by measuring changes in brain excitability, a marker of brain plasticity, with non-invasive brain stimulation; 2) BDNF levels by measuring the blood concentration of this protein; 3) Genotype by identifying the subtype of BDNF gene carried by each participant; 4) Cardiorespiratory fitness by assessing the performance during a graded exercise test.

Statistical analysis: Differences between exercise and control groups on the primary endpoint of all outcomes will be analyzed with linear mixed models. Besides baseline scores, sex, age, and type of stroke (cortical or subcortical) will be included as covariates because they can affect brain plasticity and BDNF response. T1 scores will also be included to increase the efficiency of the model. The influence of genotype on changes in primary and secondary outcomes in the exercise group will be inspected with the Freedman-Schatzkin test, a powerful technique to identify mediators of change that can be used in small-scale exercise studies.

Expected outcomes: Cardiovascular exercise will promote positive changes in brain excitability and will increase blood BDNF levels in individuals in the early phases of stroke recovery. However, the individual response to this type of exercise in relation to brain plasticity and BDNF levels will be influenced by the genotype of each participant.

Relevance: It is important to establish whether cardiovascular exercise enhances brain reorganization early after stroke post-stroke and whether genetic factors may influence the response to this intervention. This will provide clinicians with useful information which will be essential to design more individualized exercise-based treatments to optimize functional recovery in individuals with stroke.

Impact: The first weeks after a stroke are critical for functional recovery. After this initial period, the rate of recovery slows down and functional improvements become much more difficult to achieve. In Canada, health-care costs in the 6 months after stroke amount to $2.8 billion/year. Finding cost-effective rehabilitation strategies to promote recovery during the early phases post-stroke is essential to help patients return to an independent living.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals 40-80 years old
  • Who had a first-ever ischemic (cortical or subcortical) stroke confirmed by MRI/CT
  • Who had stroke 2 to 6 weeks prior to participation
  • With recordable motor-evoked potentials (MEPs) elicited with transcranial magnetic stimulation (TMS) from the affected hemisphere
  • With no serious musculoskeletal or neurological conditions other than stroke
  • With sufficient cognitive/communicative capacity to safely perform the protocols.

Exclusion criteria

  • Hemorrhagic stroke
  • Cognitive impairment/dysphasia affecting informed consent
  • Concurrently enrolled in another exercise program
  • Major psychiatric or previous neurological disease
  • Absolute contraindications to TMS or exercise

Treatment and study plan

Cardiovascular Training

Behavioral

8 weeks of cardiovascular training

Other names: CT

Standard Therapy

Behavioral

8 weeks of Standard Therapy

Other names: ST

Primary outcomes

  1. Cortico-spinal excitability

    Time frame: 8 weeks

    Single pulse motor-evoked potentials of transcranial magnetic stimulation protocol.

  2. Intra-cortical inhibition

    Time frame: 8 weeks

    Paired-pulse motor-evoked potentials of transcranial magnetic stimulation protocol.

  3. Intra-cortical facilitation

    Time frame: 8 weeks

    Paired-pulse motor-evoked potentials of transcranial magnetic stimulation protocol.

Secondary outcomes

  1. Brain-derived neurotrophic factor

    Time frame: 8 weeks

    5 ml of blood will be placed into lab tubes and centrifuged. Blood plasma will be pipetted into lab wells and stored in a -80 ̊C freezer for analysis with an ELISA kit sensitive to protein and mature BDNF.

  2. Cardiorespiratory fitness

    Time frame: 8 weeks

    We will determine the maximum oxygen consumption (VO2peak) achieved during the graded exercise test as we have shown in previous studies.

Sponsors and collaborators

Lead sponsor

McGill University

Other

Registry information

Official study title

Promoting Brain Plasticity During Sub-acute Stroke: the Interactive Role of Exercise and Genotype

Important dates

Study start
2021
Primary completion
2023
Study completion
2024
First posted
Oct 13, 2021
Registry last updated
Dec 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.